Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Transplantation

Molecular diagnosis of kidney transplant rejection

Acute or chronic antibody-mediated rejection (ABMR) of kidney allografts is currently diagnosed by the presence of donor-specific alloantibodies and distinct pathological findings in biopsy samples. A new study highlights the potential of molecular diagnostics incorporated into standard criteria for acute ABMR to help identify patients at risk of graft loss.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Loupy, A. et al. Molecular microscope strategy to improve risk stratification in early antibody-mediated kidney allograft rejection. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2013111149.

  2. 2

    Hidalgo, L. G. et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am. J. Transplant. 9, 2532–2541 (2009).

    CAS  Article  Google Scholar 

  3. 3

    Haas, M. et al. Banff meeting report: inclusion of C4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am. J. Transplant. 14, 272–283 (2013).

    Article  Google Scholar 

  4. 4

    Sis, B. et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am. J. Transplant. 9, 2312–2323 (2009).

    CAS  Article  Google Scholar 

  5. 5

    Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transplant. 10, 1812–1822 (2010).

    CAS  Article  Google Scholar 

  6. 6

    Sellares, J. et al. Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am. J. Transplant. 13, 971–983 (2013).

    CAS  Article  Google Scholar 

  7. 7

    Halloran, P. F. et al. Microarray diagnosis of antibody-mediated rejection in kidney transplant biopsies: an international prospective study (INTERCOM). Am. J. Transplant. 13, 2865–2874 (2013).

    CAS  Article  Google Scholar 

  8. 8

    Volk, H. D., Sawitzki, B. & Reinke, P. Molecular analysis of renal allograft biopsies—more than a nice toy for researchers? Am. J. Transplant. 13, 539–540 (2013).

    CAS  Article  Google Scholar 

  9. 9

    Sinn, P. et al. Multigene assays for classification, prognosis, and prediction in breast cancer: a critical review on the background and clinical utility [German]. Geburtshilfe Frauenheilkd. 73, 932–940 (2013).

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors thank Dr Geraldine Rauch at the Institute of Medical Biostatics and Professor Burkhard Tönshoff at the University Children's Hospital, University of Heidelberg, Germany, for helpful discussions.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Martin Zeier.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Morath, C., Zeier, M. Molecular diagnosis of kidney transplant rejection. Nat Rev Nephrol 10, 429–430 (2014). https://doi.org/10.1038/nrneph.2014.106

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing